Shopping Cart 0
Cart Subtotal
AED 0

BerryPharma AG - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 642

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1285

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1927

Details

BerryPharma AG-Strategy, SWOT and Corporate Finance Report

Summary

BerryPharma AG-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

BerryPharma AG (BerryPharma), the trademark of Iprona AG, is a manufacturer and distributor of liquid and powdered polyphenol products. The company manufactures polyphenol fruit powders, polyphenol liquids, polyphenol extract powders of red berries, such as elderberries, blackcurrants, bilberries, chokeberries (aronia), and cranberries. BerryPharma also offers customized fruit extracts based on its client requirement. Its products are offered to a number of industries including food, beverages, healthcare, cosmetics and pharmaceuticals. Its cooperation includes the Universities in Giessen and Dusseldorf (Germany), the German Institute for Nutrition in Karlsruhe, the China Medical University in Taiwan, the Scottish Crop and Research Institute, the Charite in Berlin, and the Kuopio University in Finland. BerryPharma is headquartered in Lana, South Tyrol, Italy.

Scope

- Detailed information on BerryPharma AG required for business and competitor intelligence needs

- A study of the major internal and external factors affecting BerryPharma AG in the form of a SWOT analysis

- An in-depth view of the business model of BerryPharma AG including a breakdown and examination of key business segments

- Intelligence on BerryPharma AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about BerryPharma AG, such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of BerryPharma AG and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess BerryPharma AG as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on BerryPharma AG's business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot

Table of Contents

BerryPharma AG: Company Overview

BerryPharma AG: Overview and Key Facts

BerryPharma AG: Overview

BerryPharma AG: Key Facts

BerryPharma AG: Major Products and Services

BerryPharma AG: Company History

BerryPharma AG: Locations and Subsidiaries

BerryPharma AG: Key Competitors

BerryPharma AG: Company Analysis

BerryPharma AG: Business Description

BerryPharma AG: SWOT Analysis

BerryPharma AG: SWOT Overview

BerryPharma AG: Strengths

BerryPharma AG: Weaknesses

BerryPharma AG: Opportunities

BerryPharma AG: Threats

Appendix

Contact Us

Methodology

About MarketLine


List Of Table

List of Tables

Table 1: BerryPharma AG: Key Facts

Table 2: BerryPharma AG: Company History

Table 3: BerryPharma AG: Locations and Subsidiaries

Table 4: BerryPharma AG: Key Competitors

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

BerryPharma AG-Strategy, SWOT and Corporate Finance Report

Summary

BerryPharma AG-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

BerryPharma AG (BerryPharma), the trademark of Iprona AG, is a manufacturer and distributor of liquid and powdered polyphenol products. The company manufactures polyphenol fruit powders, polyphenol liquids, polyphenol extract powders of red berries, such as elderberries, blackcurrants, bilberries, chokeberries (aronia), and cranberries. BerryPharma also offers customized fruit extracts based on its client requirement. Its products are offered to a number of industries including food, beverages, healthcare, cosmetics and pharmaceuticals. Its cooperation includes the Universities in Giessen and Dusseldorf (Germany), the German Institute for Nutrition in Karlsruhe, the China Medical University in Taiwan, the Scottish Crop and Research Institute, the Charite in Berlin, and the Kuopio University in Finland. BerryPharma is headquartered in Lana, South Tyrol, Italy.

Scope

- Detailed information on BerryPharma AG required for business and competitor intelligence needs

- A study of the major internal and external factors affecting BerryPharma AG in the form of a SWOT analysis

- An in-depth view of the business model of BerryPharma AG including a breakdown and examination of key business segments

- Intelligence on BerryPharma AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about BerryPharma AG, such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of BerryPharma AG and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess BerryPharma AG as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on BerryPharma AG's business structure, strategy and prospects.

READ MORE

Scope

Table of Contents

Company Snapshot

Table of Contents

BerryPharma AG: Company Overview

BerryPharma AG: Overview and Key Facts

BerryPharma AG: Overview

BerryPharma AG: Key Facts

BerryPharma AG: Major Products and Services

BerryPharma AG: Company History

BerryPharma AG: Locations and Subsidiaries

BerryPharma AG: Key Competitors

BerryPharma AG: Company Analysis

BerryPharma AG: Business Description

BerryPharma AG: SWOT Analysis

BerryPharma AG: SWOT Overview

BerryPharma AG: Strengths

BerryPharma AG: Weaknesses

BerryPharma AG: Opportunities

BerryPharma AG: Threats

Appendix

Contact Us

Methodology

About MarketLine


List Of Table

List of Tables

Table 1: BerryPharma AG: Key Facts

Table 2: BerryPharma AG: Company History

Table 3: BerryPharma AG: Locations and Subsidiaries

Table 4: BerryPharma AG: Key Competitors

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS